dimephosphon has been researched along with Disease Models, Animal in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arsent'eva, EV; Avdeĭkina, OI; Mosina, LM; Tarasova, TV | 1 |
Moiseeva, IIa; Rodina, OP | 1 |
Mosina, LM; Plotnikova, NA; Rodina, OP; Vlasov, AP | 1 |
Aleksandrova, AE; Shchegoleva, RA; Shcherbakova, NM; Zabolotnykh, NV | 1 |
4 other study(ies) available for dimephosphon and Disease Models, Animal
Article | Year |
---|---|
[Prevention of ulcerogenesis at experimental pancreatitis].
Topics: Animals; Anti-Ulcer Agents; Disease Models, Animal; Dogs; Duodenal Ulcer; Duodenum; Female; Lipid Peroxidation; Male; Organophosphorus Compounds; Pancreas; Pancreatitis | 2009 |
[Comparison of stress protector activity of drugs with antioxidant activity (vitamin E, dimephosphon, reamberin) in rats].
Topics: Animals; Antioxidants; Catalase; Chromatography, Thin Layer; Disease Models, Animal; Female; Lipid Peroxidation; Male; Malondialdehyde; Meglumine; Organophosphorus Compounds; Oxidative Stress; Phospholipases A2; Rats; Stomach Ulcer; Succinates; Superoxide Dismutase; Vitamin E | 2011 |
[Experimental assessment of the effect of dimephosphone on ulcerogenesis].
Topics: Animals; Antioxidants; Catalase; Disease Models, Animal; Gastric Mucosa; Indomethacin; Intestine, Small; Lipid Peroxides; Liver; Mucous Membrane; Organophosphorus Compounds; Peptic Ulcer; Peptic Ulcer Hemorrhage; Phospholipases A; Rats; Stomach | 2004 |
[Use of dimephosphon in pathogenetic therapy of experimental tuberculosis].
Topics: Animals; Antitubercular Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation, Preclinical; Drug Therapy, Combination; In Vitro Techniques; Isoniazid; Lung; Mice; Mycobacterium bovis; Organophosphorus Compounds; Tuberculosis, Pulmonary | 1991 |